Virginia Tightens Vape and Tobacco Retail Enforcement, With Fines Up to $15,000 Per Unlisted Product

Jul.20
Virginia Tightens Vape and Tobacco Retail Enforcement, With Fines Up to $15,000 Per Unlisted Product
A new Virginia law that took effect on July 1, 2026, requires retailers to obtain permits to sell liquid nicotine, vape and tobacco products, while directing Virginia ABC to conduct inspections and verify that stores sell only products listed in the state directory.

Key Points

  • A new Virginia law took effect on July 1, 2026, expanding enforcement over vape and tobacco retail sales.
  • Retailers must obtain permits to sell liquid nicotine, vape and tobacco products.
  • Businesses have until October to apply, with a $400 application fee.
  • Virginia ABC will conduct inspections, including unannounced underage buyer operations.
  • Retailers may sell only products listed in the state’s official certification directory.
  • Fines for selling unlisted products can rise from $5,000 to $15,000 per product.

2Firsts

July 20, 2026

According to the Virginia Attorney General’s Office, a new state law took effect on July 1, 2026, giving the office expanded authority to hold businesses accountable for illegal sales of vape and tobacco products. Attorney General Jay Jones said his office will use the new authority to crack down on illegal products and keep vape and tobacco products out of the hands of minors.

Augusta Free Press reported that the law requires retail stores in Virginia to obtain permits to sell liquid nicotine, vape and tobacco products. Businesses have until October to apply for the permits, which carry a $400 application fee. The fee will help fund new enforcement positions at the Virginia Alcoholic Beverage Control Authority, known as Virginia ABC.

Retail Permits and Regular Inspections Are Central to the Law

Under the law, Virginia ABC will lead retail enforcement for vape and tobacco products, including minimum-age requirements and checks to ensure retailers sell only products included in the state’s official directory.

The law requires at least one unannounced underage buyer operation every 24 months to verify that permit holders are not selling retail tobacco products to people under 21.

The measure moves Virginia’s retail oversight beyond age restrictions alone and toward a system combining permits, inspections and product-directory verification.

Unlisted Products Face Per-Item Penalties

Another focus of the new law is ensuring that retailers sell only products listed in Virginia’s official Liquid Nicotine and Vapor Product Certification Directory.

The Virginia Attorney General’s Office hosts and maintains the directory. According to Augusta Free Press, the directory lists liquid nicotine and nicotine vapor product manufacturers and products for which current and accurate certification forms have been submitted.

Violations involving the sale of products not listed in the directory are subject to per-product penalties: $5,000 per product for a first violation, $10,000 per product for a second violation and $15,000 per product for a third violation.

That structure means penalties could increase quickly if a retailer sells multiple unlisted liquid nicotine or vape products.

Attorney General Says Office Will Hold Illegal Sellers Accountable

Virginia Attorney General Jay Jones said his office is prepared to act under the new authority.

Jones said businesses pushing illegal products will be held accountable, and that those breaking the law will face enforcement action.

He also said the state views local zoning efforts as part of a broader partnership. Local governments know their communities best, Jones said, describing the effort as a state and local partnership.

Youth Vape Use Remains a Public Health Concern

Augusta Free Press cited the Virginia Foundation for Healthy Youth’s 2024 annual report, which said the smoking rate among high school students fell from 28.6% in 2001 to 2% in 2024. At the same time, 8.1% of high school students reported using e-cigarettes or vapes in 2023.

The figures show that while combustible cigarette smoking has fallen sharply among students, youth vaping remains a concern for state officials and public health agencies.

Virginia’s new law therefore focuses on two issues: preventing underage purchases and ensuring that retailers sell only products that meet state directory requirements.

State-Level Enforcement Puts More Responsibility on Retailers

Virginia’s new law shows how U.S. state-level vape regulation is increasingly placing responsibility on retail sellers.

Rather than relying only on the federal FDA premarket authorization system, states are using permits, product directories, random checks and per-item penalties to push compliance obligations directly onto convenience stores, smoke shops and other retailers.

For the liquid nicotine and vape industry, whether a product is listed in a state directory and whether retailers can pass age-verification and product-compliance checks will become increasingly important to market access.

Follow 2Firsts for the latest updates on global tobacco harm reduction, nicotine products and regulatory developments.

Cover Image source: Virginia Attorney General’s Office


Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Australia Adds 6-Methylnicotine to Schedule 9 Prohibited Substances, Effective October 1
Australia Adds 6-Methylnicotine to Schedule 9 Prohibited Substances, Effective October 1
Australia's Therapeutic Goods Administration published a final decision on September 25 to classify 6-methylnicotine as a Schedule 9 prohibited substance under the Poisons Standard, effective October 1, 2026. TGA said the chemical has been reported in e-cigarette liquids sold in Australia and marketed as nicotine-free or nicotine alternatives, while evidence also indicates its use in preparations such as oral pouches. The government originally proposed a Schedule 7 classification but ultimately adopted the stricter Schedule 9 designation, citing acute toxicity, dependence risk, use in unapproved consumer products and misleading marketing.
News
Sep.29 by 2Firsts Perspectives
FDA Unifies Tobacco Registration and Product Listing Form Across Product Categories
FDA Unifies Tobacco Registration and Product Listing Form Across Product Categories
The U.S. FDA has consolidated two tobacco establishment registration and product listing forms into a redesigned Form FDA 3741 covering all regulated product categories, including e-cigarettes, heated tobacco products and nicotine pouches. The current requirements remain limited to domestic establishments. Separately, the FDA has proposed extending registration and product listing requirements to foreign manufacturers, signaling greater regulatory attention to manufacturing entities and product-level information across the tobacco and nicotine supply chain.
FDA
Sep.30
GAO Audit Finds Nearly 132,000 FDA Tobacco Applications Waiting an Average 1,266 Days as Nicotine Pouch Pilot Practices Move Into Vape PMTA Reviews
GAO Audit Finds Nearly 132,000 FDA Tobacco Applications Waiting an Average 1,266 Days as Nicotine Pouch Pilot Practices Move Into Vape PMTA Reviews
A U.S. Government Accountability Office audit found that 131,915 tobacco product applications submitted to the FDA since 2018 remained without a final review as of December 31, 2025, with pending applications waiting an average of 1,266 days. GAO also found FDA lacks the data needed to systematically determine whether scientific reviews meet applicable timelines. HHS agreed to upgrade the agency's tracking systems. At the same time, FDA has begun applying lessons from its nicotine pouch PMTA pilot to e-cigarette reviews, while changes to enforcement policy and electronic submissions are making the specific stage of a PMTA increasingly relevant to market access.
FDA
Oct.03
Pennsylvania Vape Directory Enforcement Starts Oct. 19, Barring Retail Sales of Unlisted Products
Pennsylvania Vape Directory Enforcement Starts Oct. 19, Barring Retail Sales of Unlisted Products
Pennsylvania's Act 57 vape directory regime will reach the end of its 120-day inventory transition period on Oct. 19. Nicotine-containing e-cigarettes intended for retail sale in the state that are not listed on the Attorney General's ENDS directory will then be barred from retail sale and treated as contraband subject to seizure, forfeiture and destruction. Manufacturers face annual product certification, brand- and style-based fees and a minimum $50,000 surety bond, while retailers and wholesalers must source through licensed channels and monitor the directory.
Regulations
Oct.08
Canada Health Minister Says She Is Not Considering Looser Nicotine Pouch Retail Rules as PMI-Linked Group Pushes for Wider Access
Canada Health Minister Says She Is Not Considering Looser Nicotine Pouch Retail Rules as PMI-Linked Group Pushes for Wider Access
Canadian Health Minister Marjorie Michel says she is not considering loosening retail restrictions on nicotine pouches. Canada regulates pouches containing 4 mg or less of nicotine per unit as non-prescription nicotine replacement therapy and requires newer NRT formats such as pouches to be sold from behind pharmacy counters. Meanwhile, Unsmoke Canada, linked to Philip Morris International's Canadian business, is pushing to allow pouches in convenience stores and other general retail outlets. Health Canada also acknowledges continued unauthorized sales, while recent research shows rising pouch use among Canadian youth aged 16 to 19.
Sep.24
NAS 2026 | Cliff Douglas: Risk Continuum Should Play a Central Role in Tobacco Policy
NAS 2026 | Cliff Douglas: Risk Continuum Should Play a Central Role in Tobacco Policy
Cliff Douglas, a veteran U.S. tobacco-control and public health policy figure, told NAS 2026 that the “continuum of risk” should play a central role in tobacco policy. He called for clearer market pathways, stronger risk communication, differentiated regulation and enforcement, and said possible FDA reforms to PMTA reviews could be a “welcome correction” if they create a more efficient, predictable route for scientifically substantiated lower-risk products. Read 2Firsts’ on-site coverage.
Sep.26